Trade Summary

3 months ago, Lucas Svetlana, serving as Dir at Jasper Therapeutics, Inc. (JSPR), purchased 20,000 shares at $2.43 per share, for a total transaction value of $48,600.00. Following this transaction, Lucas Svetlana now holds 20,000 shares of JSPR.

The trade was executed on Monday, September 22, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, September 24, 2025, 2 days after the trade was made.

Jasper Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.